NCT05466149 2025-11-19Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 InsertionAllist Pharmaceuticals, Inc.Phase 2 Active not recruiting100 enrolled